Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1093/jnci/95.8.625
Read article for free, from open access legal sources, via Unpaywall: https://academic.oup.com/jnci/article-pdf/95/8/625/9835311/625.pdf
References
Articles referenced by this article (11)
Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade.
Recent Prog Horm Res, 127-155 2001
MED: 11237210
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
Cell, (4):557-563 1990
MED: 2406025
Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Cancer Res, (11):4526-4535 2001
MED: 11389085
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway.
Oncogene, (34):3948-3954 2000
MED: 10951588
p44/p42-MAP kinase expression in papillary thyroid carcinomas.
Surgery, (6):936-940 2001
MED: 11742320
Show 1 more reference (10 of 11)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Article citations
Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review).
Exp Ther Med, 27(4):149, 20 Feb 2024
Cited by: 2 articles | PMID: 38476918 | PMCID: PMC10928970
Review Free full text in Europe PMC
Genomic alterations in thyroid cancer: biological and clinical insights.
Nat Rev Endocrinol, 20(2):93-110, 04 Dec 2023
Cited by: 17 articles | PMID: 38049644
Review
BRAFV600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration.
Sci Rep, 13(1):17129, 10 Oct 2023
Cited by: 4 articles | PMID: 37816788 | PMCID: PMC10564976
How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?
Front Endocrinol (Lausanne), 14:1270796, 04 Oct 2023
Cited by: 0 articles | PMID: 37859987 | PMCID: PMC10582750
Tumor Cell Resistance to the Inhibition of BRAF and MEK1/2.
Int J Mol Sci, 24(19):14837, 02 Oct 2023
Cited by: 3 articles | PMID: 37834284 | PMCID: PMC10573597
Review Free full text in Europe PMC
Go to all (530) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas.
J Clin Endocrinol Metab, 89(5):2414-2420, 01 May 2004
Cited by: 158 articles | PMID: 15126572
Lack of BRAF mutation in primary uveal melanoma.
Invest Ophthalmol Vis Sci, 44(7):2876-2878, 01 Jul 2003
Cited by: 76 articles | PMID: 12824225
A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells.
Thyroid, 14(11):910-915, 01 Nov 2004
Cited by: 36 articles | PMID: 15671769
[BRAF gene mutation in thyroid cancer].
Pol Merkur Lekarski, 20(116):210-213, 01 Feb 2006
Cited by: 0 articles | PMID: 16708643
Review